This website is intended for healthcare professionals only and contains promotional content.

Report an adverse event here
Link Logo

NOTICE: Kyowa Kirin International has agreed a joint venture with Grünenthal GmbH for the Established Medicines portfolio. The new company, KKI NewCo (known as Grünenthal Meds), is responsible for the content on this page. For more information please click here.​

Treatment Guidelines: Vitamin D Deficiency

Guidelines for the treatment and management of vitamin D deficiency:

NICE:
Vitamin D: supplement use in specific population groups

This guideline aims to increase supplement use to prevent vitamin D deficiency among specific population groups, as identified in 2012 by the UK Health Departments (Vitamin D – advice on supplements for at risk groups – letter from UK Chief Medical Officers Department of Health), and in 2016 by the Scientific Advisory Committee on Nutrition's vitamin D and health report.

https://www.nice.org.uk/guidance/ph56

Royal Osteoporosis Society:
Vitamin D and Bone Health: A Practical Clinical Guideline for Patient Management

The Royal Osteoporosis Society published a practical clinical guideline in 2013 on the management of vitamin D deficiency in adult patients with, or at risk of developing bone disease. The guideline has now been updated by a group of clinicians and scientists with expertise in vitamin D and osteoporosis, using evidence from the Institute of Medicine (IOM) Report in 2010 and the Scientific Advisory Committee on Nutrition (SACN) Report on Vitamin D and Health in 2016, supplemented by the identification of papers published subsequently.

https://strwebprdmedia.blob.core.windows.net/media/ef2ideu2/ros-vitamin-d-and-bone-health-in-adults-february- 2020.pdf

Average: